Targeting pancreatic cancer with combined inhibition of EGFR and RAF.

Brandstetter J, Goldstein L, Schreiber T, Palme R, Lindner T, Joksch M, Krause B, Vollmar B, Kumstel S.

PLoS One. 2026 Apr 24;21(4):e0347843.